CVS Health (NYSE:CVS) Director Sells $95,508,760.00 in Stock

CVS Health Corporation (NYSE:CVS) Director Larry Robbins sold 1,018,000 shares of the firm’s stock in a transaction dated Wednesday, May 20th. The shares were sold at an average price of $93.82, for a total value of $95,508,760.00. Following the sale, the director owned 5,195,261 shares of the company’s stock, valued at $487,419,387.02. This represents a 16.38% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Larry Robbins also recently made the following trade(s):

• On Thursday, May 21st, Larry Robbins sold 370,462 shares of CVS Health stock. The shares were sold at an average price of $93.45, for a total value of $34,619,673.90.
• On Tuesday, May 19th, Larry Robbins sold 1,983,538 shares of CVS Health stock. The shares were sold at an average price of $94.45, for a total value of $187,345,164.10.

CVS Health Stock Up 0.1%

Shares of CVS traded up $0.07 during trading on Thursday, reaching $93.35. The company’s stock had a trading volume of 6,478,498 shares, compared to its average volume of 8,694,289. The company has a market cap of $119.11 billion, a price-to-earnings ratio of 41.12, a P/E/G ratio of 0.92 and a beta of 0.60. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.78. CVS Health Corporation has a twelve month low of $58.50 and a twelve month high of $98.43. The company has a fifty day moving average of $79.69 and a two-hundred day moving average of $78.87.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, May 6th. The pharmacy operator reported $2.57 earnings per share for the quarter, topping the consensus estimate of $2.21 by $0.36. The company had revenue of $100.43 billion during the quarter, compared to analyst estimates of $94.99 billion. CVS Health had a net margin of 0.72% and a return on equity of 11.88%. The firm’s revenue for the quarter was up 6.2% compared to the same quarter last year. During the same period last year, the business earned $2.25 EPS. CVS Health has set its FY 2026 guidance at 7.300-7.500 EPS. On average, sell-side analysts predict that CVS Health Corporation will post 7.44 EPS for the current fiscal year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, May 4th. Shareholders of record on Thursday, April 23rd were paid a dividend of $0.665 per share. The ex-dividend date was Thursday, April 23rd. This represents a $2.66 annualized dividend and a yield of 2.8%. CVS Health’s dividend payout ratio is presently 117.18%.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on CVS. Robert W. Baird boosted their price objective on shares of CVS Health from $92.00 to $94.00 and gave the company an “outperform” rating in a research report on Wednesday, April 15th. Bank of America cut their price target on CVS Health from $100.00 to $95.00 and set a “buy” rating on the stock in a report on Tuesday, January 27th. The Goldman Sachs Group boosted their price objective on CVS Health from $95.00 to $97.00 and gave the company a “buy” rating in a research report on Thursday, February 12th. Piper Sandler dropped their target price on CVS Health from $101.00 to $99.00 and set an “overweight” rating on the stock in a research report on Tuesday, March 31st. Finally, Leerink Partners reiterated an “outperform” rating and issued a $98.00 target price on shares of CVS Health in a research note on Thursday, March 5th. Twenty-two investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $98.68.

Trending Headlines about CVS Health

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Glenview Capital publicly praised CVS Health’s progress, saying its concentrated position has returned 80% since May 2024 and highlighting the company’s ongoing turnaround, which may reinforce bullish investor sentiment. Glenview Capital Issues Statement on CVS Health
• Positive Sentiment: CVS also continued to announce community-focused initiatives, including senior affordable housing in New Jersey and programs supporting military families and maternal mental health, which may modestly support its reputation but are unlikely to move the stock on their own. CVS Health, Diocese of Camden, and The Walters Group Unite to Bring Senior Affordable Housing to Williamstown, New Jersey
• Neutral Sentiment: Additional company-newsroom items on maternal mental health, military support, and Aetna Better Health’s food-access program are positive from a branding standpoint, but they appear mostly promotional and have limited direct financial impact. Aetna Better Health of Louisiana Collaborates With Goodr To Launch Mobile Food Market and Chronic Care Program
• Negative Sentiment: Two hospital systems accused CVS of profiting from a “secret pricing scheme” tied to the federal 340B drug discount program, with combined alleged damages above $60 million. The lawsuits add legal, financial, and reputational risk, which could weigh on the shares. CVS Health Lawsuits Test 340B Practices And Investor Risk Assessment

Hedge Funds Weigh In On CVS Health

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Royal Fund Management LLC boosted its position in shares of CVS Health by 30.2% during the first quarter. Royal Fund Management LLC now owns 88,301 shares of the pharmacy operator’s stock worth $6,342,000 after buying an additional 20,471 shares during the period. Edgestream Partners L.P. acquired a new position in shares of CVS Health during the first quarter worth approximately $657,000. Kentucky Retirement Systems boosted its position in shares of CVS Health by 25.0% during the first quarter. Kentucky Retirement Systems now owns 98,269 shares of the pharmacy operator’s stock worth $7,033,000 after buying an additional 19,633 shares during the period. Bull Harbor Capital LLC acquired a new position in shares of CVS Health during the first quarter worth approximately $345,000. Finally, Strategic Investment Advisors MI increased its holdings in shares of CVS Health by 9.6% during the first quarter. Strategic Investment Advisors MI now owns 9,741 shares of the pharmacy operator’s stock valued at $700,000 after purchasing an additional 853 shares during the period. 80.66% of the stock is currently owned by institutional investors and hedge funds.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over?the?counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in?store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk?in medical clinics and HealthHUB locations that offer expanded clinical services.